170 related articles for article (PubMed ID: 2838050)
1. Immunobiology of CR2, the B lymphocyte receptor for Epstein-Barr virus and the C3d complement fragment.
Cooper NR; Moore MD; Nemerow GR
Annu Rev Immunol; 1988; 6():85-113. PubMed ID: 2838050
[No Abstract] [Full Text] [Related]
2. Activation of B lymphocytes by Epstein-Barr virus/CR2 receptor interaction.
Masucci MG; Szigeti R; Ernberg I; Hu CP; Torsteinsdottir S; Frade R; Klein E
Eur J Immunol; 1987 Jun; 17(6):815-20. PubMed ID: 3036539
[TBL] [Abstract][Full Text] [Related]
3. Studies of the Epstein Barr virus receptor found on Raji cells. II. A comparison of lymphocyte binding sites for Epstein Barr virus and C3d.
Hutt-Fletcher LM; Fowler E; Lambris JD; Feighny RJ; Simmons JG; Ross GD
J Immunol; 1983 Mar; 130(3):1309-12. PubMed ID: 6218205
[TBL] [Abstract][Full Text] [Related]
4. Deficiency of Epstein-Barr virus (EBV) receptors on B lymphocytes from certain patients with common varied agammaglobulinemia.
Schwaber JF; Klein G; Ernberg I; Rosen A; Lazarus H; Rosen FS
J Immunol; 1980 May; 124(5):2191-6. PubMed ID: 6245136
[No Abstract] [Full Text] [Related]
5. Purification of the Epstein-Barr virus/C3d complement receptor of human B lymphocytes: antigenic and functional properties of the purified protein.
Nemerow GR; Siaw MF; Cooper NR
J Virol; 1986 May; 58(2):709-12. PubMed ID: 2422399
[TBL] [Abstract][Full Text] [Related]
6. Cell cycle control of a Burkitt lymphoma cell line: responsiveness to growth signals engaging the C3D/EBV receptor.
Pernegger G; Schulz TF; Hosp M; Myones BL; Petzer AL; Eigentler A; Böck G; Wick G; Dierich MP
Immunology; 1988 Oct; 65(2):237-41. PubMed ID: 2461345
[TBL] [Abstract][Full Text] [Related]
7. The Epstein-Barr virus receptor on two nasopharyngeal carcinoma model cell lines.
Takimoto T; Umeda R; Glaser R
Acta Virol; 1989 Aug; 33(4):375-7. PubMed ID: 2574946
[TBL] [Abstract][Full Text] [Related]
8. Analysis of epitope expression and the functional repertoire of recombinant complement receptor 2 (CR2/CD21) in mouse and human cells.
Carel JC; Frazier B; Ley TJ; Holers VM
J Immunol; 1989 Aug; 143(3):923-30. PubMed ID: 2473114
[TBL] [Abstract][Full Text] [Related]
9. Incorporation of the purified Epstein Barr virus/C3d receptor (CR2) into liposomes and demonstration of its dual ligand binding functions.
Mold C; Cooper NR; Nemerow GR
J Immunol; 1986 Jun; 136(11):4140-5. PubMed ID: 3009615
[TBL] [Abstract][Full Text] [Related]
10. Binding of C3 and C3dg to the CR2 complement receptor induces growth of an Epstein-Barr virus-positive human B cell line.
Hatzfeld A; Fischer E; Levesque JP; Perrin R; Hatzfeld J; Kazatchkine MD
J Immunol; 1988 Jan; 140(1):170-5. PubMed ID: 2826586
[TBL] [Abstract][Full Text] [Related]
11. Biochemical and antigenic analysis of the Epstein Barr virus/C3d receptor (CR2).
Siaw MF; Nemerow GR; Cooper NR
J Immunol; 1986 Jun; 136(11):4146-51. PubMed ID: 3009616
[TBL] [Abstract][Full Text] [Related]
12. Binding of monoclonal antibody to the Epstein Barr virus (EBV)/CR2 receptor induces activation and differentiation of human B lymphocytes.
Nemerow GR; McNaughton ME; Cooper NR
J Immunol; 1985 Nov; 135(5):3068-73. PubMed ID: 2995485
[TBL] [Abstract][Full Text] [Related]
13. Epstein Barr virus binding induces internalization of the C3d receptor: a novel immunotoxin delivery system.
Tedder TF; Goldmacher VS; Lambert JM; Schlossman SF
J Immunol; 1986 Aug; 137(4):1387-91. PubMed ID: 3016095
[TBL] [Abstract][Full Text] [Related]
14. Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes.
Weis JJ; Tedder TF; Fearon DT
Proc Natl Acad Sci U S A; 1984 Feb; 81(3):881-5. PubMed ID: 6230668
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus/complement fragment C3d receptor (CR2) reacts with p53, a cellular antioncogene-encoded membrane phosphoprotein: detection by polyclonal anti-idiotypic anti-CR2 antibodies.
Barel M; Fiandino A; Lyamani F; Frade R
Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10054-8. PubMed ID: 2557614
[TBL] [Abstract][Full Text] [Related]
16. Purification of the B lymphocyte receptor for the C3d fragment of complement and the Epstein-Barr virus by monoclonal antibody affinity chromatography, and assessment of its functional capacities.
Weis JJ; Richards SA; Smith JA; Fearon DT
J Immunol Methods; 1986 Aug; 92(1):79-87. PubMed ID: 3018085
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2).
Nemerow GR; Wolfert R; McNaughton ME; Cooper NR
J Virol; 1985 Aug; 55(2):347-51. PubMed ID: 2410629
[TBL] [Abstract][Full Text] [Related]
18. Structure of the human B lymphocyte receptor for C3d and the Epstein-Barr virus and relatedness to other members of the family of C3/C4 binding proteins.
Weis JJ; Toothaker LE; Smith JA; Weis JH; Fearon DT
J Exp Med; 1988 Mar; 167(3):1047-66. PubMed ID: 2832506
[TBL] [Abstract][Full Text] [Related]
19. Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21).
Ahearn JM; Fearon DT
Adv Immunol; 1989; 46():183-219. PubMed ID: 2551147
[No Abstract] [Full Text] [Related]
20. Identification of a partial cDNA clone for the C3d/Epstein-Barr virus receptor of human B lymphocytes: homology with the receptor for fragments C3b and C4b of the third and fourth components of complement.
Weis JJ; Fearon DT; Klickstein LB; Wong WW; Richards SA; de Bruyn Kops A; Smith JA; Weis JH
Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5639-43. PubMed ID: 3016712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]